慢性下肢浅静脉功能不全腔内治疗可及性差异:全国7年分析
该回顾性研究利用美国外科医师学会国家手术质量改进计划数据库,分析2011至2018年21,025例接受静脉剥脱术或腔内热消融治疗的慢性浅静脉疾病患者。西班牙裔患者接受腔内热消融相对于静脉剥脱术的比值比显著降低,美国印第安/阿拉斯加原住民患者则更高;所有种族和族裔组中腔内手术比例增加而静脉剥脱术减少。
要点
- 西班牙裔患者接受腔内热消融相对于静脉剥脱术的比值比显著降低(OR 0.71,95%CI 0.64-0.78,P < .001)。
- 美国印第安/阿拉斯加原住民患者接受腔内热消融相对于静脉剥脱术的比值比更高(OR 4.02,95%CI 2.48-6.86)。
- 所有种族和族裔组中腔内手术百分比增加,而静脉剥脱术减少。
核心结论
- 基于医院数据集,人口学指标包括年龄、性别、种族和族裔与慢性浅静脉功能不全腔内治疗差异相关,提示某些患者群体在获得微创治疗选项方面存在差异。
研究设计与样本
- 回顾性研究,免于机构审查委员会批准,使用美国外科医师学会国家手术质量改进计划数据库识别2011至2018年接受静脉剥脱术和腔内手术(射频消融和激光消融)治疗慢性浅静脉疾病的患者,共纳入21,025例。
主要发现
- 总体平均年龄54.2岁,大多数患者为女性(64.8%)。
- 27.9%、55.2%和16.9%的患者分别接受静脉剥脱术、射频消融和激光消融。
- 接受激光消融的患者年龄更大(P < .001)。
- 西班牙裔与非西班牙裔相比,接受腔内热消融相对于静脉剥脱术的比值比显著降低(OR 0.71,95%CI 0.64-0.78,P < .001)。
- 美国印第安/阿拉斯加原住民患者接受腔内热消融相对于静脉剥脱术的比值比更高(OR 4.02,95%CI 2.48-6.86);夏威夷原住民/太平洋岛民患者也更高,但差异未达统计学显著(OR 1.44,95%CI 0.93-2.27)。
关键数值与推荐
- 西班牙裔患者接受射频消融相对于静脉剥脱术的比值比降低,美国印第安/阿拉斯加原住民患者接受射频消融相对于静脉剥脱术的比值比更高(多项式回归)。
- 所有种族和族裔组中腔内手术百分比增加,而静脉剥脱术减少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of this study was to analyze trends in treatment access for chronic superficial venous disease and to identify disparities in care. METHODS: This retrospective study was exempt from institutional review board approval. The American College of Surgeon National Surgical Quality Improvement Program database was used to identify patients who underwent vein stripping (VS) and endovenous procedures for treatment of chronic superficial venous disease. Endovenous options included radiofrequency ablation (RFA) and laser ablation. Data was available from 2011 to 2018 and demographic information was extracted for each patient identified by Current Procedural Terminology codes. For all racial and ethnic groups, trend lines were plotted, and the relative rate of change was determined within each specified demographic. RESULTS: There were 21,025 patients included in the analysis. The overall mean age was 54.2 years, and the majority of patients were female (64.8%). In total, 27.9%, 55.2%, and 16.9% patients underwent VS, RFA, and laser ablation, respectively. Patients who received laser ablation were older (P < .001). Hispanic ethnicity was associated with significantly lower odds of receiving endovascular thermal ablation (EVTA) over VS (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.64-0.78; P < .001). American Indian/Alaska Native patients were more likely to receive EVTA over VS (OR, 4.02; 95% CI, 2.48-6.86); similarly, Native Hawaiian/Pacific Islander patients were more likely to receive EVTA over VS, although this difference was not statistically significant (OR, 1.44; 95% CI, 0.93-2.27). On multinomial regression, Hispanic patients were less likely to receive RFA over VS, whereas American Indian/Alaskan Native patients were more likely to receive RFA over VS. In all racial and ethnic groups, the percentage of endovenous procedures increased, whereas vein stripping decreased. CONCLUSIONS: Based on a hospital-based dataset, demographic indicators, including age, sex, race, and ethnicity, are associated with differences in endovenous treatments for chronic superficial venous insufficiency suggesting disparities in obtaining minimally invasive treatment options among certain patient groups.
引用
- Chan SM, Tabari A, Rudié E, et al. Disparities in access to endovenous treatment options in chronic lower extremity superficial venous insufficiency: A national 7-year analysis. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38452897. doi:10.1016/j.jvsv.2024.101867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。